Abstract
Purpose
Nocardiosis is a life-threatening infectious disease. We aimed at describing nocardiosis in patients with primary immunodeficiency diseases (PID).
Methods
This international retrospective cohort included patients with PID and nocardiosis diagnosed and/or published from Jan 1, 2000, to Dec 31, 2016. To identify nocardiosis cases, we analyzed PID databases from the French National Reference Center for PID (Paris, France) and the National Institute of Health (NIH, United States of America) and we performed a literature review on PubMed.
Results
Forty-nine cases of nocardiosis associated with PID were included: median age at diagnosis of nocardiosis was 19 (0–56) years and most cases were observed among chronic granulomatous disease (CGD) patients (87.8%). Median time from symptoms to diagnosis of Nocardia infection was 20 (2–257) days. Most frequent clinical nocardiosis presentation was pneumonia (86.7%). Twelve-month mortality rate was 4.2%, and 11.9% of patients experienced a possible recurrence of infection. Nocardiosis more frequently led to the diagnosis of PID among non-CGD patients than in CGD patients. Non-CGD patients experienced more cerebral nocardiosis and more disseminated infections, but mortality and recurrence rates were similar. Highest incidences of nocardiosis among PID cohorts were observed among CGD patients (0.0057 and 0.0044 cases/patient-year in the USA and in France, respectively), followed by IL-12p40 deficiency.
Conclusions
Among 49 cases of nocardiosis associated with PID, most patients had CGD and lung involvement. Both mortality and recurrence rates were low.
Similar content being viewed by others
Abbreviations
- ABT:
-
Antibiotic therapy
- AST:
-
Antibiotic susceptibility testing
- ADA:
-
Adenosine deaminase
- BAL:
-
Bronchoalveolar lavage
- CGD:
-
Chronic Granulomatous Disease
- CEREDIH:
-
Centre de Référence des Déficits Immunitaires Héréditaires
- CNS:
-
Central nervous system
- COPD:
-
Chronic obstructive pulmonary disease
- CS:
-
Corticosteroids
- CVID:
-
Common variable immunodeficiency
- HIV:
-
Human virus immunodeficiency
- HCST:
-
Hematopoietic stem cell transplantation
- ICL:
-
Idiopathic CD4 Lymphocytopenia
- IL12RB1:
-
Interleukine-12 and Interleukine-23 receptor β1 chain deficiency
- IL-12p40 deficiency:
-
Interleukine-12p40 deficiency
- NIH:
-
National Institute of Health
- STAT1 GoF:
-
Signal transducer and activator of transcription 1 gain-of-function
- STAT3 LoF:
-
Deficiency of the signal transducer and activator of transcription 3
- TMP-SMX:
-
Trimethoprim–sulfamethoxazole
- USA:
-
United States of America
References
Beaman L, Beaman BL. Differences in the interactions of Nocardia asteroides with macrophage, endothelial, and astrocytoma cell lines. Infect Immun. 1994;62:1787–98.
Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006;19:259–82. https://doi.org/10.1128/CMR.19.2.259-282.2006.
Lebeaux D, Freund R, van Delden C, Guillot H, Marbus SD, Matignon M, et al. Outcome and treatment of nocardiosis after solid organ transplantation: new insights from a European study. Clin Infect Dis. 2017;64:1396–405. https://doi.org/10.1093/cid/cix124.
Coussement J, Lebeaux D, van Delden C, Guillot H, Freund R, Marbus S, et al. Nocardia infection in solid organ transplant recipients: a multicenter European case-control study. Clin Infect Dis. 2016;63:338–45. https://doi.org/10.1093/cid/ciw241.
Wang H-L, Seo Y-H, LaSala PR, Tarrand JJ, Han XY. Nocardiosis in 132 patients with cancer: microbiological and clinical analyses. Am J Clin Pathol. 2014;142:513–23. https://doi.org/10.1309/AJCPW84AFTUWMHYU.
Rosen LB, Rocha Pereira N, Figueiredo C, Fiske LC, Ressner RA, Hong JC, et al. Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated/extrapulmonary nocardiosis. Clin Infect Dis. 2015;60:1017–25. https://doi.org/10.1093/cid/ciu968.
Marciano BE, Spalding C, Fitzgerald A, Mann D, Brown T, Osgood S, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2015;60:1176–83. https://doi.org/10.1093/cid/ciu1154.
Dorman SE, Guide SV, Conville PS, DeCarlo ES, Malech HL, Gallin JI, et al. Nocardia infection in chronic granulomatous disease. Clin Infect Dis. 2002;35:390–4. https://doi.org/10.1086/341416.
Freeman AF, Marciano BE, Anderson VL, Uzel G, Costas C, Holland SM. Corticosteroids in the treatment of severe nocardia pneumonia in chronic granulomatous disease. Pediatr Infect Dis J. 2011;30:806–8. https://doi.org/10.1097/INF.0b013e318218181d.
Gaafar A, Unzaga MJ, Cisterna R, Leal MV, Bustamante V, Triapu JM, et al. Separate Nocardia infections in a patient with chronic granulomatous disease. J Clin Microbiol. 2001;39:3015–6.
Lublin M, Bartlett DL, Danforth DN, Kauffman H, Gallin JI, Malech HL, et al. Hepatic abscess in patients with chronic granulomatous disease. Ann Surg. 2002;235:383–91.
Sereti I, Holland SM. Disseminated nocardiosis in a patient with X-linked chronic granulomatous disease and human immunodeficiency virus infection. Clin Infect Dis. 2001;33:235–9. https://doi.org/10.1086/321818.
Picard C, Fieschi C, Altare F, Al-Jumaah S, Al-Hajjar S, Feinberg J, et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet. 2002;70:336–48. https://doi.org/10.1086/338625.
de Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, Feinberg J, et al. Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore). 2010;89:381–402. https://doi.org/10.1097/MD.0b013e3181fdd832.
Pedraza S, Lezana JL, Samarina A, Aldana R, Herrera MT, Boisson-Dupuis S, et al. Clinical disease caused by Klebsiella in 2 unrelated patients with interleukin 12 receptor beta1 deficiency. Pediatrics. 2010;126:e971–6. https://doi.org/10.1542/peds.2009-2504.
Prando C, Samarina A, Bustamante J, Boisson-Dupuis S, Cobat A, Picard C, et al. Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds. Medicine (Baltimore). 2013;92:109–22. https://doi.org/10.1097/MD.0b013e31828a01f9.
Oksenhendler E, Gérard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis. 2008;46:1547–54. https://doi.org/10.1086/587669.
Dunogué B, Pilmis B, Mahlaoui N, Elie C, Coignard-Biehler H, Amazzough K, et al. Chronic granulomatous disease in patients reaching adulthood: a Nationwide study in France. Clin Infect Dis. 2017;64:767–75. https://doi.org/10.1093/cid/ciw837.
Régent A, Autran B, Carcelain G, Cheynier R, Terrier B, Charmeteau-De Muylder B, et al. Idiopathic CD4 lymphocytopenia: clinical and immunologic characteristics and follow-up of 40 patients. Medicine (Baltimore). 2014;93:61–72. https://doi.org/10.1097/MD.0000000000000017.
Donadieu J, Beaupain B, Fenneteau O, Bellanné-Chantelot C. Congenital neutropenia in the era of genomics: classification, diagnosis, and natural history. Br J Haematol. 2017;179:557–74. https://doi.org/10.1111/bjh.14887.
Vignesh P, Rawat A, Kumar A, Suri D, Gupta A, Lau YL, et al. Chronic granulomatous disease due to neutrophil cytosolic factor (NCF2) gene mutations in three unrelated families. J Clin Immunol. 2017;37:109–12. https://doi.org/10.1007/s10875-016-0366-2.
Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 2019;7:1763–70. https://doi.org/10.1016/j.jaip.2019.02.004.
Scott-Algara D, Balabanian K, Chakrabarti LA, Mouthon L, Dromer F, Didier C, et al. Idiopathic CD4+ T-cell lymphocytopenia is associated with impaired membrane expression of the chemokine receptor CXCR4. Blood. 2010;115:3708–17. https://doi.org/10.1182/blood-2009-02-202796.
Rouzaud C, Rodriguez-Nava V, Catherinot E, Méchaï F, Bergeron E, Farfour E, et al. Clinical assessment of a Nocardia PCR-based assay for diagnosis of Nocardiosis. J Clin Microbiol. 2018;56. https://doi.org/10.1128/JCM.00002-18.
Blosser SJ, Drake SK, Andrasko JL, Henderson CM, Kamboj K, Antonara S, et al. Multicenter matrix-assisted laser desorption ionization-time of flight mass spectrometry study for identification of clinically relevant Nocardia spp. J Clin Microbiol. 2016;54:1251–8. https://doi.org/10.1128/JCM.02942-15.
Conville PS, Zelazny AM, Witebsky FG. Analysis of secA1 gene sequences for identification of Nocardia species. J Clin Microbiol. 2006;44:2760–6. https://doi.org/10.1128/JCM.00155-06.
Lebeaux D, Bergeron E, Berthet J, Djadi-Prat J, Mouniée D, Boiron P, et al. Antibiotic susceptibility testing and species identification of Nocardia isolates: a retrospective analysis of data from a French expert laboratory, 2010-2015. Clin Microbiol Infect. 2018;25:489–95. https://doi.org/10.1016/j.cmi.2018.06.013.
Schlaberg R, Fisher MA, Hanson KE. Susceptibility profiles of Nocardia isolates based on current taxonomy. Antimicrob Agents Chemother. 2014;58:795–800. https://doi.org/10.1128/AAC.01531-13.
Valdezate S, Garrido N, Carrasco G, Medina-Pascual MJ, Villalón P, Navarro AM, et al. Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain. J Antimicrob Chemother. 2017;72:754–61. https://doi.org/10.1093/jac/dkw489.
Lambert M-L, Hasker E, Van Deun A, Roberfroid D, Boelaert M, Van der Stuyft P. Recurrence in tuberculosis: relapse or reinfection? Lancet Infect Dis. 2003;3:282–7.
Picard C, Al-Herz W, Bousfiha A, Casanova J-L, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency 2015. J Clin Immunol. 2015;35:696–726. https://doi.org/10.1007/s10875-015-0201-1.
Lee WS, Boey CC, Goh AY. Pulmonary nocardiosis in a child with hyperimmunoglobulin E syndrome. Singap Med J. 1999;40:278–80.
Luangwedchakarn V, Jirapongsaranuruk O, NiemeLa JE, Thepthai C, Chokephaibulkit K, Sukpanichnant S, et al. A novel mutation of the IL12RB1 gene in a child with nocardiosis, recurrent salmonellosis and neurofibromatosis type I: first case report from Thailand. Asian Pac J Allergy Immunol. 2009;27:161–5.
Göktay F, Mansur AT, Erşahin M, Adaleti R, Güneş P. Idiopathic CD4+ T lymphocytopenia with epidermodysplasia verruciformis-like skin eruption, Nocardia farcinica brain abscesses and pulmonary tuberculosis: a case report with fatal outcome. J Dermatol. 2011;38:930–3.
Hagerman A, Rodríguez-Nava V, Boiron P, Crisinel P-A, Posfay-Barbe KM. Imipenem-resistant Nocardia cyriacigeorgica infection in a child with chronic granulomatous disease. J Clin Microbiol. 2011;49:1185–7. https://doi.org/10.1128/JCM.02073-10.
Ahmad DS, Esmadi M, Steinmann WC. Idiopathic CD4 Lymphocytopenia: Spectrum of opportunistic infections, malignancies, and autoimmune diseases. Avicenna J Med. 2013;3:37–47. https://doi.org/10.4103/2231-0770.114121.
Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123:809–21. https://doi.org/10.1182/blood-2013-07-515528.
Adjamian N, Kikam A, Wessell KR, Casselman J, Toller-Artis E, Olasokan O, et al. Nocardia brain abscess and CD4(+) lymphocytopenia in a previously healthy individual. Case Rep Immunol. 2015;2015:374956–3. https://doi.org/10.1155/2015/374956.
Zerbe CS, Marciano BE, Katial RK, Santos CB, Adamo N, Hsu AP, et al. Progressive multifocal leukoencephalopathy in primary immune deficiencies: Stat1 gain of function and review of the literature. Clin Infect Dis. 2016;62:986–94. https://doi.org/10.1093/cid/civ1220.
Haussaire D, Fournier P-E, Djiguiba K, Moal V, Legris T, Purgus R, et al. Nocardiosis in the south of France over a 10-years period, 2004-2014. Int J Infect Dis. 2017;57:13–20. https://doi.org/10.1016/j.ijid.2017.01.005.
Lebeaux D, Morelon E, Suarez F, Lanternier F, Scemla A, Frange P, et al. Nocardiosis in transplant recipients. Eur J Clin Microbiol Infect Dis. 2014;33:689–702. https://doi.org/10.1007/s10096-013-2015-5.
Mahlaoui N, Picard C, Bach P, Costes L, Courteille V, Ranohavimparany A, et al. Genetic diagnosis of primary immunodeficiencies: a survey of the French national registry. J Allergy Clin Immunol. 2019;143:1646–1649.e10. https://doi.org/10.1016/j.jaci.2018.12.994.
Punatar, et al. Opportunistic infections in patients with pulmonary alveolar proteinosis. J Infect. 2012. https://doi.org/10.1016/j.jinf.2012.03.020.
Minero MV, Marín M, Cercenado E, Rabadán PM, Bouza E, Muñoz P. Nocardiosis at the turn of the century. Medicine (Baltimore). 2009;88:250–61. https://doi.org/10.1097/MD.0b013e3181afa1c8.
Hui, et al. Pulmonary nocardiosis re-visited: experience of 35 patients at diagnosis. Respir Med. 2003. https://doi.org/10.1053/rmed.2003.1505.
Farina et al. Report of human nocardiosis in Italy between 1993 and 1997. Eur J Epidemiol 2001. https://doi.org/10.1023/a:1020010826300, 17, 1022.
Huang, et al. Characteristics of nocardiosis patients with different immune status from a Chinese tertiary general hospital during 8-year period: a STROBE-compliment observational study. Medicine (Baltimore). 2019. https://doi.org/10.1097/MD.0000000000017913.
Rafiei, et al. Central nervous system nocardiosis in Queensland: a report of 20 cases and review of the literature. Medicine (Baltimore). 2016. https://doi.org/10.1097/MD.0000000000005255.
Peleg AY, Husain S, Qureshi ZA, Silveira FP, Sarumi M, Shutt KA, et al. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis. 2007;44:1307–14. https://doi.org/10.1086/514340.
Aguilar C, Malphettes M, Donadieu J, Chandesris O, Coignard-Biehler H, Catherinot E, et al. Prevention of infections during primary immunodeficiency. Clin Infect Dis. 2014;59:1462–70. https://doi.org/10.1093/cid/ciu646.
Acknowledgments
We wish to thank Marion Malphettes, Jean Donadieu, and all members of the CEREDIH for their help in this work.
Authorship Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Emmanuel Lafont, Beatriz Marciano, and David Lebeaux. The first draft of the manuscript was written by Emmanuel Lafont, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Funding
Funding for this study was provided in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclaimer
The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
This research study was conducted retrospectively from data obtained for clinical purposes. This work was conducted in compliance with the French law “loi Jardé” (décret n°2016–1537, published on November 16, 2016). Ethical approval was waived by the local Ethics Committee of Necker-hospital and CEREES (Comité d’expertise pour les recherches, les études, et les évaluations dans le domaine de la santé). Regarding cases from the USA, the Institutional Review Board 93I0119 approved this study (IRIS Reference # 538437).
Consent to Participate
All patients were informed that their medical data were used and that they could refuse to participate by contacting the corresponding author by mail, e-mail or telephone.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
ESM 1
(DOCX 22.0 kb)
Rights and permissions
About this article
Cite this article
Lafont, E., Marciano, B.E., Mahlaoui, N. et al. Nocardiosis Associated with Primary Immunodeficiencies (Nocar-DIP): an International Retrospective Study and Literature Review. J Clin Immunol 40, 1144–1155 (2020). https://doi.org/10.1007/s10875-020-00866-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-020-00866-8